QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
LON:DOCS

Dr. Martens (DOCS) Share Forecast, Price & News

GBX 127
-2.82 (-2.17%)
(As of 06/8/2023 ET)
Compare
Today's Range
125.50
131.30
50-Day Range
132.10
171.25
52-Week Range
125.50
295.21
Volume
2.18 million shs
Average Volume
2.30 million shs
Market Capitalization
£1.27 billion
P/E Ratio
982.69
Dividend Yield
4.72%
Price Target
GBX 221.25

Dr. Martens MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
73.2% Upside
GBX 221.25 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.69mentions of Dr. Martens in the last 14 days
Based on 7 Articles This Week
Insider Trading
Acquiring Shares
£1.24 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.53 out of 5 stars


DOCS stock logo

About Dr. Martens (LON:DOCS) Stock

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter.

DOCS Stock News Headlines

Dr. Martens plc (LON:DOCS) Insider Buys £5,440 in Stock
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Docs smarting at profit margins
Dr. Martens plc (LON:DOCS) Declares Dividend of GBX 4.28
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Dr Martens tripped up by tough U.S. market
The 12 Best Ankle Boots of 2023 To Wear Everywhere
See More Headlines

DOCS Price History

DOCS Company Calendar

Today
6/08/2023
Ex-Dividend for 7/18 Dividend
6/08/2023
Dividend Payable
7/18/2023

Industry, Sector and Symbol

Industry
Footwear & Accessories
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,897
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 221.25
High Stock Price Forecast
GBX 350
Low Stock Price Forecast
GBX 175
Forecasted Upside/Downside
+73.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
£177.30 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£957 million
Cash Flow
GBX 8.94 per share
Book Value
GBX 35 per share

Miscellaneous

Outstanding Shares
1,000,000,000
Free Float
N/A
Market Cap
£1.28 billion
Optionable
Not Optionable
Beta
0.08

Key Executives

  • Mr. Kenneth Wilson (Age 56)
    CEO & Director
    Comp: $750k
  • Mr. Jon W. Mortimore
    CFO & Director
  • Mr. Geert Peeters (Age 57)
    Chief Operating Officer
  • Mr. Ronald Garricks
    Chief Information Officer
  • Ms. Emily Reichwald
    Gen. Counsel & Company Sec.
  • Ms. Meg Johnson
    Chief Marketing Officer
  • Ms. Sue Gannon
    Chief HR Officer
  • Mr. Lorenzo Moretti
    Pres of EMEA
  • Mr. Sean O'Neill
    Chief Digital Officer
  • Mr. Derek Chan
    Pres of APAC













DOCS Stock - Frequently Asked Questions

Should I buy or sell Dr. Martens stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DOCS shares.
View DOCS analyst ratings
or view top-rated stocks.

What is Dr. Martens' stock price forecast for 2023?

4 analysts have issued 1 year target prices for Dr. Martens' shares. Their DOCS share price forecasts range from GBX 175 to GBX 350. On average, they anticipate the company's share price to reach GBX 221.25 in the next twelve months. This suggests a possible upside of 73.2% from the stock's current price.
View analysts price targets for DOCS
or view top-rated stocks among Wall Street analysts.

How have DOCS shares performed in 2023?

Dr. Martens' stock was trading at GBX 190.60 at the beginning of 2023. Since then, DOCS stock has decreased by 33.0% and is now trading at GBX 127.75.
View the best growth stocks for 2023 here
.

How often does Dr. Martens pay dividends? What is the dividend yield for Dr. Martens?

Dr. Martens announced a dividend on Thursday, June 1st. Investors of record on Thursday, June 8th will be paid a dividend of GBX 4.28 per share on Tuesday, July 18th. This represents a yield of 2.74%. The ex-dividend date of this dividend is Thursday, June 8th. This is a boost from the stock's previous dividend of GBX 1.56. The official announcement can be accessed at this link.
Read our dividend analysis for DOCS
.

Is Dr. Martens a good dividend stock?

Dr. Martens (LON:DOCS) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 4.35%. DOCS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 4,615.38%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for DOCS.

What is Dr. Martens' stock symbol?

Dr. Martens trades on the London Stock Exchange (LON) under the ticker symbol "DOCS."

How do I buy shares of Dr. Martens?

Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Dr. Martens' stock price today?

One share of DOCS stock can currently be purchased for approximately GBX 127.75.

How much money does Dr. Martens make?

Dr. Martens (LON:DOCS) has a market capitalization of £1.28 billion and generates £957 million in revenue each year. The company earns £177.30 million in net income (profit) each year or GBX 0.13 on an earnings per share basis.

How many employees does Dr. Martens have?

The company employs 1,897 workers across the globe.

How can I contact Dr. Martens?

The official website for the company is www.drmartensplc.com. The company can be reached via phone at 44 12 1415 7047.

This page (LON:DOCS) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -